Nektar is Good Money Medicine
Howdy folks I hope everyone is well! We wanted to recap on a stock that we said was a good investment during the summer. On 19 June our analyst said that Nektar (NKTR) was a buy, so let's see how she did.
At the time of alert NKTR closed in stock price at $18.39 and today (01 Nov) she closed at $23.37 which is a gain of 27.08%! She achieved this price twice from day of alert to now, so if you wanted to profits could have been taken on 24 July when she hit a high of $23.80. So to break it down say one wanted to put $1000 to work in this name then he or she would have increased that by $270! Wow name me a passive investment (index funds) or savings account that pays like that? Consider the time frame as well, four and a half months. Furthermore, she had a recent high of $25.02 on 05 October and if you had taken profits there then now we're talking +36.05% returns!
So where is she going next? Well difficult to say with earnings coming up 07 November and I would stay out of the name. I'm just not seeing smart money pouring into it (meaning I don't see large investors buying her up). However that doesn't mean she is toxic. It means that I would sit on the sidelines for now. Overall I like what this company is doing in oncology. Emerald Chase will keep you posted...in the mean time ask yourself "how hard is your savings account working to make you more money?"
NKTR *green arrow notates buy alert on 19 June 2017
